Cargando…

Management of intractable epistaxis in patients who received radiation therapy for nasopharyngeal carcinoma

To report clinical manifestations, bleeding point localization, and outcomes of management in 16 patients with 16 instances of intractable epistaxis after radiation therapy for nasopharyngeal carcinoma. Retrospective chart review of 16 patients with nasopharyngeal carcinoma (mean age 52.06 ± 14.37 y...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Cheng-Cheng, Si, Yong-feng, Xie, Yu-an, Yu, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3758511/
https://www.ncbi.nlm.nih.gov/pubmed/23846664
http://dx.doi.org/10.1007/s00405-013-2598-6
_version_ 1782477139334922240
author He, Cheng-Cheng
Si, Yong-feng
Xie, Yu-an
Yu, Lei
author_facet He, Cheng-Cheng
Si, Yong-feng
Xie, Yu-an
Yu, Lei
author_sort He, Cheng-Cheng
collection PubMed
description To report clinical manifestations, bleeding point localization, and outcomes of management in 16 patients with 16 instances of intractable epistaxis after radiation therapy for nasopharyngeal carcinoma. Retrospective chart review of 16 patients with nasopharyngeal carcinoma (mean age 52.06 ± 14.37 years) with 16 instances of intractable epistaxis during the past 5 years, whose diagnosis was confirmed by angiography (n = 10) or MRI/CT imaging studies and clinical manifestations (n = 6). The mean radiation dose to the affected carotid artery was 101.37 ± 34.85 Gy. Bleeding points were detected in the internal carotid artery (n = 8) or external carotid artery (n = 8). Detachable balloons were used in one affected artery for vascular occlusion; six were treated using an absorbable gelatin sponge (n = 4) or microcoils (diameter 1 mm) (n = 2). Endovascular embolization was successful in seven radiation carotid blowout syndromes with cessation of hemorrhage. One patient underwent external carotid artery ligation and one patient recovered without treatment. The clinical follow-up was 3 months. Therapeutic endovascular embolization of intractable epistaxis is both efficient and safe. It should be considered as the primary treatment modality in intractable epistaxis of nasopharyngeal carcinoma.
format Online
Article
Text
id pubmed-3758511
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-37585112013-09-04 Management of intractable epistaxis in patients who received radiation therapy for nasopharyngeal carcinoma He, Cheng-Cheng Si, Yong-feng Xie, Yu-an Yu, Lei Eur Arch Otorhinolaryngol Miscellaneous To report clinical manifestations, bleeding point localization, and outcomes of management in 16 patients with 16 instances of intractable epistaxis after radiation therapy for nasopharyngeal carcinoma. Retrospective chart review of 16 patients with nasopharyngeal carcinoma (mean age 52.06 ± 14.37 years) with 16 instances of intractable epistaxis during the past 5 years, whose diagnosis was confirmed by angiography (n = 10) or MRI/CT imaging studies and clinical manifestations (n = 6). The mean radiation dose to the affected carotid artery was 101.37 ± 34.85 Gy. Bleeding points were detected in the internal carotid artery (n = 8) or external carotid artery (n = 8). Detachable balloons were used in one affected artery for vascular occlusion; six were treated using an absorbable gelatin sponge (n = 4) or microcoils (diameter 1 mm) (n = 2). Endovascular embolization was successful in seven radiation carotid blowout syndromes with cessation of hemorrhage. One patient underwent external carotid artery ligation and one patient recovered without treatment. The clinical follow-up was 3 months. Therapeutic endovascular embolization of intractable epistaxis is both efficient and safe. It should be considered as the primary treatment modality in intractable epistaxis of nasopharyngeal carcinoma. Springer Berlin Heidelberg 2013-07-12 2013 /pmc/articles/PMC3758511/ /pubmed/23846664 http://dx.doi.org/10.1007/s00405-013-2598-6 Text en © The Author(s) 2013 https://creativecommons.org/licenses/by/2.0/ Open AccessThis article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Miscellaneous
He, Cheng-Cheng
Si, Yong-feng
Xie, Yu-an
Yu, Lei
Management of intractable epistaxis in patients who received radiation therapy for nasopharyngeal carcinoma
title Management of intractable epistaxis in patients who received radiation therapy for nasopharyngeal carcinoma
title_full Management of intractable epistaxis in patients who received radiation therapy for nasopharyngeal carcinoma
title_fullStr Management of intractable epistaxis in patients who received radiation therapy for nasopharyngeal carcinoma
title_full_unstemmed Management of intractable epistaxis in patients who received radiation therapy for nasopharyngeal carcinoma
title_short Management of intractable epistaxis in patients who received radiation therapy for nasopharyngeal carcinoma
title_sort management of intractable epistaxis in patients who received radiation therapy for nasopharyngeal carcinoma
topic Miscellaneous
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3758511/
https://www.ncbi.nlm.nih.gov/pubmed/23846664
http://dx.doi.org/10.1007/s00405-013-2598-6
work_keys_str_mv AT hechengcheng managementofintractableepistaxisinpatientswhoreceivedradiationtherapyfornasopharyngealcarcinoma
AT siyongfeng managementofintractableepistaxisinpatientswhoreceivedradiationtherapyfornasopharyngealcarcinoma
AT xieyuan managementofintractableepistaxisinpatientswhoreceivedradiationtherapyfornasopharyngealcarcinoma
AT yulei managementofintractableepistaxisinpatientswhoreceivedradiationtherapyfornasopharyngealcarcinoma